Calprotectin levels were increased by 17% in patients with type 2 diabetes compared with non-diabetes patients, and by 9% in smokers compared with non-smokers, however, the latter did not reach statistical significance ( Table 4 ).
← all excerpts
Calprotectin and platelet aggregation in patients with stable coronary artery disease.
1
—
—